Fort Point Capital Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$899K Buy
2,554
+48
+2% +$17.1K 0.11% 103
2025
Q4
$827K Sell
2,506
-367
-13% -$116K 0.09% 115
2025
Q3
$811K Sell
2,873
-277
-9% -$80.3K 0.1% 118
2025
Q2
$880K Sell
3,150
-304
-9% -$86.1K 0.06% 159
2025
Q1
$1.08M Sell
3,454
-609
-15% -$180K 0.12% 118
2024
Q4
$1.06M Buy
4,063
+168
+4% +$49.8K 0.12% 121
2024
Q3
$1.26M Sell
3,895
-145
-4% -$47.4K 0.15% 94
2024
Q2
$1.26M Sell
4,040
-771
-16% -$227K 0.16% 98
2024
Q1
$1.37M Hold
4,811
0.18% 89
2023
Q4
$1.39M Sell
4,811
-767
-14% -$209K 0.2% 83
2023
Q3
$1.5M Buy
5,578
+78
+1% +$19.5K 0.23% 75
2023
Q2
$1.22M Buy
5,500
+935
+20% +$217K 0.17% 84
2023
Q1
$1.1M Buy
4,565
+24
+0.5% +$5.89K 0.17% 97
2022
Q4
$1.19M Hold
4,541
0.19% 88
2022
Q3
$1.02M Hold
4,541
0.17% 97
2022
Q2
$1.1M Hold
4,541
0.18% 87
2022
Q1
$1.1M Hold
4,541
0.15% 99
2021
Q4
$1.02M Sell
4,541
-5
-0.1% -$1.05K 0.14% 102
2021
Q3
$967K Buy
4,546
+33
+0.7% +$7.59K 0.15% 91
2021
Q2
$1.1M Hold
4,513
0.2% 67
2021
Q1
$1.12M Hold
4,513
0.24% 57
2020
Q4
$1.04M Sell
4,513
-7
-0.2% -$1.61K 0.24% 59
2020
Q3
$1.15M Sell
4,520
-378
-8% -$93.6K 0.29% 56
2020
Q2
$1.16M Sell
4,898
-85
-2% -$19.4K 0.36% 46
2020
Q1
$1.01M Buy
4,983
+18
+0.4% +$3.93K 0.43% 35
2019
Q4
$1.2M Hold
4,965
0.43% 36
2019
Q3
$961K Hold
4,965
0.36% 43
2019
Q2
$915K Sell
4,965
-50
-1% -$8.95K 0.36% 40
2019
Q1
$953K Sell
5,015
-7
-0.1% -$1.34K 0.42% 36
2018
Q4
$978K Sell
5,022
-100
-2% -$19.5K 0.39% 43
2018
Q3
$1.06M Buy
5,122
+120
+2% +$23.6K 0.32% 43
2018
Q2
$923K Sell
5,002
-143
-3% -$25.3K 0.31% 43
2018
Q1
$877K Sell
5,145
-359
-7% -$65.9K 0.32% 52
2017
Q4
$957K Buy
5,504
+513
+10% +$90.8K 0.45% 38
2017
Q3
$931K Buy
+4,991
New +$884K 0.45% 39
2016
Q4
Sell
-1,466
Closed -$245K 108
2016
Q3
$245K Buy
1,466
+100
+7% +$16.9K 0.11% 114
2016
Q2
$208K Buy
+1,366
New +$212K 0.1% 108

Other funds holding AMGN

Fort Point Capital Partners's AMGN Position: Q1 2026 in Review

Fort Point Capital Partners increased its Amgen (AMGN) stake by 1.9% in Q1 2026, buying an estimated $17.1K and bringing the position to 2,554 shares worth $899K. The position accounts for 0.11% of the portfolio, ranked #103.

Fort Point Capital Partners first reported a position in AMGN in Q2 2016 and has held it in 37 quarters since. The position peaked at $1.5M in Q3 2023. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Fort Point Capital Partners held 2,554 shares of Amgen worth $899K as of Q1 2026.
  • Fort Point Capital Partners bought 48 Amgen shares in Q1 2026, an estimated $17.1K.
  • Amgen made up 0.11% of Fort Point Capital Partners's portfolio in Q1 2026, its #103 holding.
  • Fort Point Capital Partners first reported a position in Amgen in Q2 2016 and has held it in 37 quarters since.
  • Fort Point Capital Partners's Amgen position peaked at $1.5M in Q3 2023.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Fort Point Capital Partners's 13F filing for Q1 2026, filed 14 May 2026.